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Abstract 
The potential of novel cyanine dyes to inhibit the insulin amyloid formation was evaluated 
using thioflavin T fluorescence assay, quantum-chemical calculations, molecular docking and 
molecular dynamics simulations. According to the ability to suppress the insulin fibrillization 
under physiological conditions the examined compounds were found to follow the order: 
trimethines > pentamethines > monomethines > heptamethines. Of these, the trimethines 3-3 and 
3-5, and pentamethines 5-3 and 5-9 almost completely prevented the protein aggregation by 
retarding both nucleation (except 3-3) and elongation processes. The quantum-chemical 
calculations revealed a complex relationship between the dye structure and its inhibitory effects. 
The molecular docking studies showed that most cyanines bind specifically to the L17 ladder of 
the B chain, located at the dry steric zipper of the insulin fibril protofilament, and form the stable 
complexes with the helices of the insulin monomer. The molecular dynamics simulations provided 
evidence for the increase of insulin helicity in the presence of cyanines. Collectively, the presented 
findings highlight two possible mechanisms by which cyanines can inhibit the insulin 
fibrillization: i) stabilization of the native protein structure followed by the retardation of the 
protein nucleation (all dyes); and ii) blocking the lateral extension of β-sheets via the dye-protein 
stacking interactions (3-3, 3-5, 5-3, 5-9). Overall, the obtained results may prove of importance 
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The formation and accumulation of particular type of protein aggregates, amyloid fibrils, in 
human tissues and organs is associated with dozens of severe disorders including Alzheimer’s 
disease (AD), Parkinson’s disease, type II diabetes, familial amyloid polyneuropathy, etc. [1,2]. 
The process of amyloid self-assembly typically consists of two consecutive phases: nucleation, in 
which partially unfolded protein monomers form an oligomeric nucleus and the subsequent growth 
phase [3]. Recent evidence points to soluble oligomers as the primary toxic species of amyloids 
presumably due to their ability to create channels in the cell membrane, followed by disruption of 
calcium homeostasis and free radical formation [4,5]. In view of this, significant efforts have been 
made towards development of the therapeutic agents that block early stages of amyloid formation 
[6,7], reduce the lifetime of toxic oligomers by acceleration of fibrillization and prevent fibril 
fragmentation [8]. The following classes of anti-amyloid drugs have been designed for the above 
purposes: i) proteins, peptides and covalently modified peptides [9,10]; ii) modified DNA [11]; 
iii) fullerenes [12]; and iv) small organic molecules [13]. The latter include: surfactants, 
copper/zinc ion chelators [13], flavonoids (e.g., oleuropein aglycone, epigallocatechin gallat, 
curcumin, etc.) [14–16], and organic dyes such as Congo red (CR) [17], azo dyes [18], etc. Among 
the above compounds, peptide inhibitors seem to be the most promising agents for prevention of 
fibrillization process in vivo due to their high biocompatibility and affinity for the amyloidogenic 
core sequence of the fibril-forming proteins [9,19]. However, small molecules have some 
advantages over peptide amyloid inhibitors, associated with their ability to easily cross the blood 
brain barrier and avoid immunological response, higher stability in biological fluids and tissues, 
lower flexibility enabling efficient binding, etc. [20–22]. In vitro studies reported a wide number 
of small-molecule inhibitors of fibrillogenesis, differing in structure and mode of inhibitory effect. 
Specifically, it has been demonstrated that: i) an orcein-related polyphenol, O4, promoted 
conversion of Aβ1−42 oligomers into mature amyloid fibrils [9]; ii) curcumin inhibited oligomer 
formation of Aβ, lysozyme and human islet amyloidogenic polypeptide [23]; iii) epigallocatechin-
gallate prevented α-synuclein and transthyretin aggregation by stabilizing native conformation of 
the protein and favoring the formation of amorphous aggregates [23]; iv) indole derivatives 
inhibited lysozyme fibrillization through affecting both nucleation and elongation stages of 
fibrillogenesis [24], etc. However, most of the above compounds have not been tested yet in 
clinical trials, and some of them, viz. curcumin [23] and di-iodo form of clioquinol [25], did not 
show effect in the prevention and treatment of AD. Furthermore, even though the existing anti-
amyloid drugs predominantly interfere with Aβ self-assembly, the exact modes of action of these 
















diseases, the design of small molecules that inhibit amyloid fibril formation is of paramount 
importance in biomedical research.  
Cyanine dyes represent a remarkable class of organic compounds, which have found 
numerous applications in theranostic of tumors [26,27] and fluorescence imaging of biomolecules 
[28,29] due to their: i) high extinction coefficients; ii) high affinity for biomolecules; iii) longwave 
absorption and emission bands (near-infrared compounds), enabling highly sensitive in vivo 
measurements due to the absence of the autofluorescence of the biological molecules in this region, 
etc. [30,31]. Furthermore, some studies showed the potential of cyanines to be employed as anti-
amyloid drugs, e.g., symmetrical cationic thiacarbocyanine N744 inhibited tau aggregation [32]. 
However, handling of cyanine-based anti-amyloid agents has been challenging due to their 
cytotoxicity and ability to self-aggregation [33], suggesting the necessity of designing novel 
inhibitors and investigating their modes of action both in vitro and in vivo. Polymethine bridge 
length, heterocyclic substituents, length of the aliphatic substituents on the nitrogen atom of 
benzazole chromophore, etc., were reported to modulate the inhibition potency of the cyanine 
inhibitors of tau aggregation [33], and therefore, the dyes, possessing these structural differences 
were selected for our study. 
This study was aimed at assessing the ability of novel cyanine dyes to prevent amyloid fibril 
formation by bovine insulin in vitro using thioflavin T assay, quantum-chemical calculations, 
molecular docking and molecular dynamics simulations. Insulin is a small helical protein hormone, 
playing a crucial role in glucose metabolism. Bovine insulin has been successfully employed to 
treat diabetes due to its high structural similarity to the human variant. Insulin amyloid deposits 
are a preclinical sign of injection-localized amyloidosis in diabetic patients, and these species were 
observed in Parkinson’s disease, as well [34,35]. Furthermore, amyloid fibrillation is a limiting 
factor in production, long-term storage and delivery of insulin pharmaceutical formulations [36]. 
In this context, the search for effective small molecular inhibitors of the pathogenic insulin 
aggregation may prove of importance for prevention of impaired absorption from the affected site 
in patients, as well as for a more cost-effective storage of insulin [36,37]. Our goals were: i) to 
estimate the kinetic parameters of insulin fibril formation in the presence of novel cyanine dyes; 
ii) to compare the influence of the polymethine bridge length and heterocyclic substituents on the 
dye ability to suppress the insulin self-assembly; iii) to establish a correlation between the 
quantum-chemical characteristics of the polymethine compounds and their inhibition potency; iv) 
to determine potential binding sites for the novel dyes in the native and fibrillar insulin; v) to 
uncover the mechanism of action of the most effective cyanine inhibitors of insulin fibrillogenesis. 
 

















The grades of reagents used for this study were as follows. Bovine insulin (≥25 USP  
 
 
Scheme 1.  
Chemical structures of the cyanine dyes under study. 
 
units/mg (HPLC)), ethylenediaminetetraacetic acid (EDTA) (purity of ≥95%), NaCl (≥99%, AR 
grade), dimethyl sulfoxide (99%, ACS reagent), methanol (99.8%, ACS reagent), N-(2-
hydroxyethyl)piperazine-N0-2-ethanesulfonic acid (Hepes) (≥99.5% (titration)), and thioflavin T 
(ThT) (≥65%) were from Sigma. Monomethine [31], trimethine [38], pentamethine [30] and 
heptamethine [39] cyanine dyes (analytical grade) (Scheme 1) were synthesized and purified by  
recrystallization from methanol in the University of Sofia, Bulgaria, as described previously. 
Phosphotungstic acid hydrate (high-purity grade) for electron microscopy was from REACHIM. 
















used without further purification. Cyanine dye stock solutions (100 μM) were prepared in dimethyl 
sulfoxide or methanol, while ThT powder was diluted in HEPES buffer (20 mM HEPES, 0.1 mM 
EDTA, 150 mM NaCl, pH 7.4) to the concentration of 150 μM. The dye concentrations were 
determined spectrophotometrically using Cary 100 UV-Vis spectrophotometer (Varian 
Instruments, Walnut Creek, CA). The extinction coefficients ( ) at absorption maxima ( abs ) for 
pentamethine (AK5-1, AK5-2, AK5-3, AK5-4, AK5-6, AK5-8, AK5-9), heptamethine (AK7-6) 
cyanine dyes in dimethyl sulfoxide, and monomethine (AK12-17, AK12-18, AK12-19, AK12-20), 
trimethine cyanine dyes (AK3-1, AK3-3, AK3-5, AK3-7, AK3-8, AK3-11) in methanol are 
presented in Table 1, while the extinction coefficient of ThT was taken as 412 23800   M
-1cm-1. 
 
2.2.The kinetics of amyloid formation monitored by thioflavin T assay 
The insulin stock solution (10 mg/ml) was prepared in 10 mM glycine buffer (pH 1.6, 150 
mM NaCl). The kinetics of insulin fibrillization was monitored by ThT assay. Specifically, 96-
well plates (black plastic with clear glass bottom, Greiner Bio-One, Frickenhausen, Germany) 
filled with ThT (10 µM), protein (20 µM) and cyanine dye (0 – control sample or 10 µM) were 
loaded into the fluorescence microplate reader (SPECTRAFluor Plus, Tecan, Austria), heated to 
37 °C and incubated under constant linear shaking (50 rpm) for up to several hours [40]. The TEM 
images of insulin fibrils formed in the absence of cyanine dyes are given in Figure S1, revealing 
the formation of the rod-like aggregates ca. ~200–500 nm in length and ca. ~20 nm in thickness 
similar to those observed by Iannuzzi et al. [41]. The ThT fluorescence was recorded over time at 
485 nm (10 nm bandpass filter) with excitation at 430 nm (35 nm bandpass filter). Three replicates, 
corresponding to three wells for each sample, were used to minimize the well-to-well variation. 
The obtained kinetic curves (Figures 2–3) represent the mean of three replicates (standard error is 
about 5 %). 
The quantitative characteristics of the fibrillization process were determined through 
approximating the time ( t ) dependence of ThT fluorescence intensity at 485 nm ( F ) with the 











,          (1) 
where 0F  and maxF  are ThT fluorescence intensities in the free form and in the presence of protein 
after the saturation has been reached, respectively; k  is the apparent rate constant for the fibril 
growth; mt  is the time needed to reach 50% of maximal fluorescence. The lag time was calculated 
















 To enhance fibril formation in the control sample, we performed a separate series of 
experiments, in which TRIS buffer (10 mM TRIS-HCl, 150 mM NaCl, pH 7.4) solutions, 
containing ThT (10 µM), insulin (20 µM) and cyanine dye (0 or 10 µM), were incubated in 
thermostat at 37 ºC under constant orbital shaking with the increased speed (115 rpm) for 115 
hours. Indeed, the revealed ThT fluorescence response was about an order of magnitude greater as 
compared to that observed in the first series of experiments (Figure S2). Structures of the protein 
aggregates grown in the presence of the most effective insulin amyloid inhibitors, viz. AK3-3, 
AK3-5, AK5-3 and AK5-9, were compared with that of the control sample, using transmission 
electron microscopy (Figure S3). 
 
2.3.Transmission electron microscopy (TEM) 
For electron microscopy assay, a 5 μl drop of the protein solution (20 μM, taken from the tested 
sample after the fibril growth has been finished) was applied to a carbon-coated grid and blotted 
after 3 min. A 10 μl drop of 1.5% (w/v) phosphotungstic acid solution was placed on the grid, 
blotted after 30 s, and then washed 2 times by deionized water and air dried. The resulting grids 
were viewed by EM-125 electron microscope (Selmi, Ukraine) (Figure S3). 
 
2.4.Quantum-chemical calculations 
The 3-21G(d,p) basis set was employed for the ground state 
0S  geometry optimization of 
cyanine dyes, which is the appropriate for the organic compounds [43]. The obtained geometries 
of the dyes were used as starting conformations for calculation of the ground state dipole moment 
( g ), the energy of the ground state ( gE ) and dihedral angles between the donor (quinoline 
moieties) and acceptor (benzazole moieties) of the dye ( ) with the 6-31G(d,p) basis set, offering 
reasonable estimates of the ground state properties [44,45]. All the above calculations were done 
by WinGamess (version 30 September 2017 R2). The optimized dye conformations were further 
used for estimation of the following descriptors by the semiempirical PM6 method (MOPAC 2016 
Version18.012L – free academic license [46]): i) the energy of the highest occupied ( EHOMO ) 
and lowest unoccupied ( ELUMO ) molecular orbitals; ii) the solvent-accessible area (CA ); iii) the 
cosmo volume (molecular volume) ( CV ); iv) the molecular length ( L ), height ( H ) and width (
W ); v) the polarizability of the molecule at the electric field strength 0 eV ( P ). The Molinspiration 
software (http://www.molinspiration.com/cgi-bin/properties) was used for the calculation of 
lipophilicity of the examined compounds ( LogP ) (http://www.vcclab.org/lab/alogps/), 
















method (http://www.vcclab.org/lab/alogps/) was employed to estimate the aqueous solubility (
LogS ) [48]. All the calculated parameters are presented in Table S1. 
 
2.5.Molecular docking studies 
The molecular docking studies were carried out to identify the possible binding sites for the 
cyanine inhibitors of insulin fibrillization (revealed by ThT assay), and to elucidate the nature of 
the interactions involved in the dye–protein complexation in the native protein monomer (taken 
from the bovine insulin hexameric form, PDB ID: 2ZP6) and amyloid fibrils (the two-
protofilament model, containing 8 strands in each protofilament, based on the crystal structure of 
the segment LVEALYL (human insulin B chain residues 11–17), and downloaded from 
http://people.mbi.ucla.edu/sawaya/jmol/fibrilmodels/) [35]. It should be noted that the human 
insulin fibrils were used because of the lack of the crystallographic model for the bovine insulin 
fibrils. Furthermore, despite being stored in pancreas in the form of hexamers, at neutral pH and 
micromolar concentrations insulin dissociates into dimers and tetramers, and at the first step of the 
aggregation it dissociates into physiologically active monomers (possessing more exposed 
hydrophobic areas that dimers), which were therefore used in the molecular docking procedure 
[40,49,50]. Finally, the structures of cyanine dye monomers, optimized in Avogadro, were 
employed for the docking studies, because the monomers were predominant in buffer solution at 
micromolar concentrations [31,38,51], and they also showed the highest affinity for amyloid fibrils 
[52] and DNA, compared to dimers and higher order aggregates [43]. The top 10 energetically 
favorable dye-protein structures were obtained using the PatchDock algorithm that is suitable for 
the protein-ligand and protein-protein complexes, and then refined by the FireDock, as described 
previously [52]. The docked complexes were viewed by the Visual Molecular Dynamics (VMD) 
software (version 1.9.3). 
 
2.6.Molecular dynamics simulation of the dye-protein complexes 
The 20 ns MD simulations were performed using GROMACS software (version 5.1) and the 
CHARMM36 force field, which is update of CHARMM27, reported to provide the best 
reproduction of the insulin experimental behavior [53]. The input files for MD calculations were 
prepared for the energetically most favourable dye-protein complexes using the web-based 
graphical interface CHARMM-GUI. The .mol2-files of AK12-17, AK3-1, AK3-3, AK5-3 and 
AK7-6 were created in OpenBabelGUI 2.4.1, using the structures drawn in MarvinSketch (.mrv 
format). The topologies of the ligands were generated using the dye .mol2-files and CHARMM 
General Force Field, and subsequently modified by replacing partial charges with those assigned 
















molecules) [54]. The temperature was set at 400 K to accelerate protein unfolding, that enabled us 
to test the stability of the free insulin monomer (2ZP6) and the most energetically favourable dye-
protein complexes obtained in docking studies. The systems were solvated in a rectangular box 
with a minimum distance of 10 Е from the protein to the edge of the box. The counter ions were 
added to neutralize and equilibrate the system. The MD simulations of the dye-protein complexes 
were carried out in the NPT ensemble. The systems were fully hydrated and contained 1 protein 
molecule (51 residues) and about 4384–4931 water molecules (the total number of atoms varied 
from 14009 to 15645). The molecular dynamic trajectories were saved every 1000 steps (1 ps 
interval) for subsequent analysis. The minimization and equilibration of the system were 
performed during 5000 (10 ps) and 500000 (1 ns) steps, respectively. The constant temperature 
conditions were provided by the V-rescale thermostat and there were no restraints in the 
simulations. The commands gmx rms, gmx rmsf, gmx gyrate and gmx sasa, included in 
GROMACS, were used to calculate the root-mean-square deviation ( RMSD ), root mean square 
fluctuations ( RMSF ), radius of gyration ( gR ), and solvent accessible surface area ( SASA) per 
residue. The analyses of the protein secondary structure and distances between the dye and protein 
centres of mass were performed in VMD (version 1.9.3), using the Tcl scripts. 
 
3. Results and discussion 
As seen in Figures 2A,B, 3A, insulin samples treated with cyanine dyes at low dye-protein 
ratio 0.5, showed 2–28 times lower ThT fluorescence intensity (coupled with much smaller 
turbidity) than a control sample (not containing the cyanine dye), that displayed the largest ThT 
fluorescence response and the highest turbidity [55,56]. Accordingly, the kinetic parameters of the 
protein fibrillization significantly differ from those of the control sample, reflecting the inhibition 
of the protein aggregation (Table 1).  
The effects of cyanine dyes on the insulin fibrillization appeared to depend on the polymethine 
bridge length of the compounds, and most dyes showed the ability to interfere with the protein 
aggregation, decreasing as follows: trimethines > pentamethines > monomethines > heptamethines 
(Table 1, max 0/F F ). It is worth noting at this point that the most effective cyanine inhibitors of tau 
aggregation also had bridge length of three carbons [35]. Furthermore, AK3-3, possessing the 
highest inhibitory potential induced the decrease in k  value of insulin fibrillization, the effect 
being similar to that of cationic carbocyanine dye N744, which reduced 
 
Table 1. 


































Control - - 986±55i 35183±500 2.7±0.1 2.15±0.02 1.4±0.1 35.7±1.4 
AK12-
17 
83200 507 715±63 8694±50 3.3±0.1 1.75±0.01 1.1±0.0 12.2±1.6 
AK12-
18 
77200 507 836±28 7532±21 4.8±0.1 1.64±0.01 1.2±0.0 9.0±0.7 
AK12-
19 
70700 517 756±54 6683±42 3.5±0.1 1.70±0.01 1.1±0.0 8.8±0.7 
AK12-
20 
59300 517 700±48 6030±76 1.6±0.1 2.11±0.04 0.9±0.0 8.6±0.7 
AK3-1 136000 628 949±8 3235±15 5.9±0.2 1.89±0.01 1.6±0.0 3.4±0.0 
AK3-3 159400 630 927±5 1232±6 0.6±0.0 4.77±0.07 1.4±0.1 1.3±0.0 
AK3-5 150000 631 911±1 1410±9 1.6±0.0 7.97±0.03 6.7±0.1 1.5±0.0 
AK3-7 161200 632 942±4 1477±10 7.8±0.6 2.77±0.01 2.5±0.0 1.6±0.0 
AK3-8 145800 652 954±5 4793±17 6.3±0.1 3.89±0.00 3.6±0.1 5.0±0.0 
AK3-
11 
153200 649 954±4 3367±23 7.9±0.2 4.60±0.01 4.3±0.0 3.5±0.0 
AK5-1 191158 652 902±27 4793±47 5.1±0.3 2.00±0.01 1.6±0.0 5.3±0.2 
AK5-2 200442 663 899±21 7634±55 8.7±0.3 2.34±0.01 2.1±0.0 8.5±0.3 
AK5-3 222041 652 943±3 2441±22 1.3±0.0 12.06±0.03 10.5±0.1 2.6±0.0 
AK5-4 212768 665 939±10 3523±35 3.1±0.1 4.60±0.02 4.0±0.1 3.8±0.1 
AK5-6 181648 660 975±17 9812±54 5.2±0.1 3.52±0.00 3.1±0.1 10.1±0.2 
AK5-8 225549 660 858±56 7590±79 5.1±0.2 1.20±0.01 0.8±0.0 8.8±0.7 
AK5-9 205688 657 940±6 2319±11 2.4±0.1 7.36±0.02 6.5±0.1 2.5±0.0 
AK7-6 208902 817 905±35 16839±100 8.6±0.3 4.17±0.00 3.9±0.0 18.6±0.8 
a – the extinction coefficients at absorption maxima (b) for cyanine dyes in dimethyl sulfoxide or methanol. 
c – ThT fluorescence intensity (at 485 nm) in the free form. 
d – ThT fluorescence intensity (at 485 nm) in the presence of protein after the saturation has been reached. 
e – the apparent rate constant for the fibril growth. 
f – the time needed to reach 50% of maximal fluorescence. 
g – the lag time of the fibril formation. 
h – ThT fluorescence response to the presence of insulin aggregates.       
h – Error bars represent standard errors of the parameters obtained by approximating the time dependence of ThT 
fluorescence intensity at 485 nm with the sigmoidal curve (1), using Origin Lab 8.0 software (Nonlinear curve fit and 
the No weighting options). 
 
the filament length of tau aggregates without altering the lag time [34]. The above finding suggests 
that it is insulin elongation (not nucleation) that is affected by the presence of AK3-3. For the 
monomethine dyes and pentamethine AK5-8, a slight drop in lag time was accompanied by a slight 
increase in the apparent rate constant for the fibril growth, although a 2-fold decrease of k  was 
observed for AK1-20. The coincubation of trimethine/pentamethine/heptamethine compounds 
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Figure 2.  
Kinetics of insulin fibrillization in the presence of monomethine (A) and pentamethine (B) cyanine 
dyes (experimental points and fitted curves). The inset (B) shows the kinetic curves for AK5-3 and 
AK5-9 in the range of 1000 – 3000 a.u. Each experimental point is the average of 3 identical 
samples. max 0/F F  value of insulin fibrillization in the presence of monomethine (C) and 
pentamethine, heptamethine (D) cyanine dyes. Protein, dye and ThT concentrations were 20, 10 
and 10 μM, respectively.  
(suppressed nucleation) and k , up to 3.2 times (enhanced elongation) compared to the control 
values, with the exception of AK3-5, AK5-3, AK5-9, which retarded the elongation and slowed 
down the nucleation of insulin fibrils. Notably, the experimental conditions affecting the 
nucleation and elongation do not always induce the changes of kinetic parameters in the same 
direction [56,57]. Taking into account the facts that the insulin secondary structure changes from 
almost completely helical to predominant β-sheets [58], and that the hydrophobic core of insulin 
(B-chain, the residues 11–17 [40]) is exposed to solvent during partial unfolding of the protein 
















supposed that the cyanine dyes are capable of stabilizing the native structure of insulin by, for 
example, preventing the destruction of α-helixes. To verify this hypothesis, we performed a 
separate series of experiments (to increase the amount of mature insulin fibrils formed in control) 
and viewed the obtained protein aggregates at TEM (Figure S3). Surprisingly, superfibrillar 
twisted structures (ca. ~ 536±36 nm in width and up to several tens of micrometers in length) 
appeared in the absence of the cyanines (Figure S3, A) [59]. In turn, fuzzy amyloid-like fibrils 
(ca. ~ 27±5 nm in width, and ca. ~ 1.2±0.1 μm in length) embedded in amorphous protein were 
observed in the presence of AK3-3 (Figure S3, B). Furthermore, spheroidal insulin assemblies 
possessing the diameters of ca. 30 – 650 nm were stabilized in the presence of AK3-5, AK5-3, 
AK5-9 (Figure S3, C–E). The latter effect was similar to that observed for insulin aggregation 
inhibited by eugenol, revealing that the cyanines can retain native protein species growing into 
mature fibrils by stabilizing large oligomers [60]. Indeed, AK3-5, AK5-3, AK5-9 appeared to be 
the most effective in preventing the insulin amyloid nucleation (i.e., extending the Lag time , 
Table 1), showing the off-pathway nature the observed spheroidal assemblies (Figure S3,C–E). 
In turn, AK3-3 inhibited only the elongation of the fibrils that resulted in the formation of the 
amyloid-containing amorphous species, being, presumably, less toxic than the large oligomers 
[61]. Interestingly, the observed insulin spherical aggregates may also represent a core of the giant 
insulin spherulites, containing few amounts of amyloid material, because they induced much lower 
ThT response as compared to that in the control sample (Figure S2) [62]. Furthermore, the native 
insulin secondary structure should be partially stabilized by the most effective cyanine inhibitors 
due to the fact that the smallest number of spheroidal aggregates, as well as the weakest ThT 
fluorescence response, were observed in the presence of AK3-5, as compared to that in the 






















Figure 3.  
Kinetics of insulin fibrillization in the presence of trimethine cyanine dyes (experimental points and 
fitted curves). The inset shows the magnified curves in the range of 1000 – 5000 a.u. Each 
experimental point is the average of 3 identical samples. (A). Kinetic parameters of insulin 
fibrillization (B–D). Protein, dye and ThT concentrations were 20, 10 and 10 μM, respectively.  
 
The ThT fluorescence studies allowed us to uncover the effects of heterocyclic substituents 
on the dye ability to suppress the protein self-assembly, viz.: i) the increase in length of the 
aliphatic substituents on the nitrogen atom of benzazole chromophore from 1 to 2 and more 
carbons enhances the inhibition potency (decreased max 0/F F ) of trimethines (AK3-3, AK3-5, 
AK3-7 compared to AK3-1) and pentamethines (AK5-3, AK5-4, AK5-9 compared to AK5-1, 
AK5-2). Interestingly, pentamethine dyes, possessing long alkyl chains in the quaternized nitrogen 
were reported to have far more higher affinity for bovine serum albumin than those with short 
substituents on the nitrogen atom of benzazole chromophore, suggesting that the novel dyes could 
inhibit amyloid fibril formation by interaction with native proteins [56]; ii) the presence of benzyl 
substituent in the N-alkyl substituents of benzazole moiety reduces the ability of AK3-11, AK5-6, 
AK7-6 to inhibit the insulin amyloid formation; iii) the replacement of S by Se in the benzazole 
heterocycle had negative impact on the inhibitory potential of AK5-2 and AK5-4 compared to 
AK5-1 and AK5-3, respectively; iv) the presence of C N  group in the N-alkyl of AK5-8 and the 
alkyl substituents in the 5-th and 6-th positions of benzazole moiety of AK3-8 decreases the dye 
inhibition potency; v) the long alkyl substituents of the quinoline ring, containing N-
methylpyrrolidine and N-methylpiperidine groups significantly reduce the ability of the 
monomethines to interfere with the insulin aggregation; vi) the OH-groups of the aliphatic 
















times higher decrease in 
max 0/F F , than other trimethines (except AK3-3, AK3-5) and 
pentamethines (except AK5-3). The latter observation is in agreement with the results of Lee, 
Kisilevsky and Mishra, who reported that molecules containing hydroxyl, sulfonate or carbonyl 
groups inhibit amyloid fibril formation due to their strong interactions with amino acids [22,63,64]. 
Notably, monomethine dyes possessing sulfonate groups did not show high inhibitory potential 
presumably due to the bulky substituents in the quinoline moieties, which may reduce the dye 
affinity for the native insulin. 
Our results showed that the monomethine compounds and heptamethine AK7-6 induced the 
least significant drop in ThT fluorescence intensity, despite the kinetic parameters provoking the 
increase of max 0/F F . These discrepancies may reflect the morphological changes in amyloid fibril 
structure (but not the decreased extent of the protein aggregation) induced by the dyes and resulting 
in the weaker ThT signal [65]. Furthermore, the monomethines represent the only class tested 
whose absorption spectra overlap with the emission band of ThT, suggesting that the Förster 
resonance energy transfer could also be responsible for the drop in ThT fluorescence (Table 1). In 
turn, AK7-6 was reported to form H-aggregates in aqueous solutions that may result in its lowest 
ability to interfere with the insulin amyloid formation [57]. In all cases, however, much lower 
turbidity of insulin solutions incubated with cyanine dyes, compared to the control sample, can be 
regarded as additional evidence for inhibition of amyloid fibril formation by this class of small 
molecules [66]. 
Notably, the examined cyanine dyes can also compete with ThT for the fibril binding sites, 
reducing the number of ThT molecules, associated with the protein assemblies [67]. Indeed, 
trimethine dyes 7519 and SH-516 were successfully employed for insulin and α-synuclein amyloid 
detection, respectively [68,69]. Similarly, monomethine dye T-284 showed high sensitivity to 
amyloid α-synuclein, despite the great impact of the substituents in the benzazole and quinoline 
moieties on the fluorescence response of the above dyes [70]. On the other hand, ThT has stronger 
affinity for insulin fibrils, as compared to other compounds (e.g., Congo Red, Nile Red) [65,70,71], 
and ThT assay is thought to be the most sensitive approach for monitoring the formation of insulin 
fibrils under acidic conditions [72], that reduces the probability of ThT competitive displacement 
from the fibril binding sites. Furthermore, while the inhibition occurs at the early stages of the 
insulin aggregation, the ability of the investigated dyes to displace ThT from the amyloid fibril 
binding sites could lead to the overestimation of their inhibitory potential, but not to a false positive 
effect. Finally, a separate series of TEM experiments showed that cyanine dyes possessing the 
highest inhibitory potential do inhibit insulin amyloid formation (Figure S3). 
To gain deeper insights into the factors that may underlie the observed effects, the above 
















molecular dynamics simulations, with particular emphasis on the mechanisms contributing to the 
inhibition of the insulin amyloid formation by the cyanine dyes. 
The quantum-chemical calculations enabled us to establish a correlation between the 
experimentally determined 
max 0/F F  values and the quantum-chemical descriptors (Table S1). 
Remarkably, most of the examined dyes possess a planar (dihedral angle   between the benzazole 
and quinoline moieties varies from 163 to 180 degrees) hydrophobic core that is the common 
feature shared between the reported amyloid inhibitors [73,74]. In turn, the nonplanar 
monomethines showed the lowest inhibition potency (Table 1). Next, TPSA , LogP , and . .Mol wt  
values for AK3-3, AK3-5, AK5-3 were similar to those obtained for the cyanine inhibitors of tau 
aggregation, e.g., compound 11, capable of penetrating the blood-brain barrier, and thus, being the 
most attractive for biological experimentations, viz. pharmacokinetics studies [33,75,76]. The high 
polarizability ( P ) of the planar cyanine dyes was supposed to account for the strong van der Waals 
interactions with a cross-β-sheet structure, followed by the stabilization of soluble tau oligomeric 
species [33,77]. Furthermore, α-helices provide the surfaces suitable for the binding of π-
delocalized ligands, as well [77]. Next, the quantitative structure-activity analysis of the 
polyphenolic inhibitors of Aβ aggregation showed negative correlation between the fibrillization 
extent and the molecular descriptors such as P , . .Mol wt , CV  and CA , indicating that the highest 
size factor leads to the greatest inhibitory effect [78]. In turn, the P  values derived for the dyes 
under investigation were lower than those reported previously, and a negative correlation between 
P , L , . .Mol wt  and the inhibitor potency 0 max/F F  was observed (the correlation coefficients were 
estimated to be RY = -0.6, -0.75 and -0.73, respectively), suggesting that either different 
mechanisms are involved in the prevention of insulin aggregation [77], or that the high ability of 
the dyes to self-associate in buffer solution and/or in the presence of native proteins prevents them 
from exerting specific inhibitory effects [79]. Indeed, the increase in cyanine dye aggregation with 
a polymethine bridge length (that is proportional to L  for all the compounds except 
heptamethines) was reported previously [80], while the binding of pentamethines and 
heptamethines to monomeric proteins turned out to shift the equilibria between various dye species 
towards the aggregate formation [30,56], in contrast to the trimethines [43], producing the largest 
decrease in max 0/F F  (Table 1). Overall, these data indicate that despite the lowest self-aggregation 
propensity the trimethines AK3-3, AK3-5 may have the strongest stacking interactions with the 
grooves on the amyloid protofibril surface, and thus, the highest ability to prevent lateral growth 
of the insulin fibrils [81], manifesting itself in the decrease of k  values compared to control (Table 
1). Notably, the advantage of the tested dyes over polyphenoles, e.g., curcumin and quercetin, is 
















formation, and thus, cyanines are less prone to exert non-specific inhibitory effects, which 
complicate the target validation [35,82]. Next, a moderate negative correlation ( RY  = -0.65) 
between 
0 max/F F  and HOMO-LUMO gaps indicates that the inhibition potency of cyanines 
increases along with their chemical reactivity, as well [83]. Likewise, only a weak correlation was 
revealed between 
0 max/F F  and the other descriptors (Table S1). Notably, the ground-state dipole 
moments of the monomethine dyes seem to be overestimated in 3-21G(d,p) basis set as judged 
from the typical values of this parameter reported for cyanine compounds [84,85], although 
leaving the monomethines out of consideration did not improve the correlation. Finally, the H  
values allowed us to suggest that the monomethines, AK5-6 and AK7-6 are unlikely to interact 
with channels running parallel to the long fibril axis, because the distance between the every 
second residue in a β-sheet is 6.5–6.95 Å [86]. Interestingly, Se has an important biological role: 
it is typically present in the active centers of human redox enzymes in the form of the 
selenocysteine that is more potent nucleophile than cysteine [87], while organoselenium molecules 
are of growing interest due to their important antioxidant properties [88–90]. According to our 
quantum-chemical calculations, replacement of S (AK5-1, AK5-2) to Se (AK5-2, AK5-4) induced 
a slight increase in the dye molecular volume and solvent-accessible area, and ~15 – 20 % decrease 
in lipophilicity (Table S1). In turn, dye molecules retained their almost planar structures (Table 
S1, torsion angle 0 ). These results show that hydrophobic dye-protein interactions are of great 
importance for the pentamethine inhibitors, leading to the ~2-fold increase in the AK5-1, AK5-3 
inhibition potency 0 max/F F  as compared to that of AK5-2, AK5-4, respectively (Table 1). 
Furthermore, the self-aggregation potency of Se-containing dyes should be lower, as compared to 
that of S-containing compounds, because Se is more potent nucleophile under physiological 
conditions [87]. However, AK5-1, AK5-3 monomers seem to form more stable complexes with 
the hydrophobic cavities of insulin and the dry steric zipper of insulin prefibrillar aggregates, than 
AK5-2, AK5-4. 
The molecular docking studies indicated that the cyanine compounds (except AK7-6) and ThT 
tend to form the most stable complexes with L17 ladder (4–6 strands) of the B chain, located on 
the dry steric zipper of the insulin fibril protofilament, with their long axes parallel to the fibril 
axis, although the angle between the AK12-17 plane and the fibril extension direction was about 
20 degrees (Figure 4) [20]. Furthermore, the above binding site also includes the residues C19 
and L6 of the first and second protofilaments (B chain), respectively. Indeed, according to the 
molecular dynamics simulations, the ladders formed from Y and L possess high-affinity for ThT 
[91]. This binding mode was prevalent for pentamethines (AK5-3), trimethines (AK3-1, AK3-3) 
















less pronounced inhibitory effect on the insulin fibrillization than the other dyes (Figure S3). 
Interestingly, despite the high thickness of some dyes (Table S1), all compounds are capable of 
associating with fibrillar insulin parallel to the long fibril axis, since the binding site resides at the 
C-termini of LVEALYL β-strands (not in the grooves formed by the side chains of amino acids) 
(Figure 4). In the most energetically favorable dye-protein complex AK7-6 was attached to the 
fibril along the β-strand direction, interacting with the residues L17, Q4 and L6 of the first and 
second protofilament (B chain), respectively (Figure 4). However, the nonspecific primary 
binding sites for AK7-6, AK12-17 (Figure S3) and other monomethines (data not shown) were 
observed, embracing the C- and N-termini of β-strands (coil structure) located at the fibril polar 
face. Most trimethines and pentamethines also associated with coil structure of the insulin fibril 
(secondary binding modes, data not shown). The analysis of the fibril binding sites revealed that 
the possibility of competitive binding of trimethine, pentamethine cyanine dyes and ThT, in 
principle, cannot be excluded. However, the inhibition of amyloid growth by, for instance, 
resveratrol, naproxen and ibuprofen was attributed to their binding to the surface grooves on the 
edge of IAPP and Aβ fibrils, followed by blocking the lateral extension of the fibril [91,92]. In our 
case, the structure of the dry steric zipper interface could be destabilized by the bound dyes, 
resulting in the prevention of insulin cross-β spine formation (Figure 4) [40,93,94]. The docking 
results coincide with the experimental data, showing that the most effective inhibitors, viz. AK3-
3, AK3-5, AK5-3 and AK5-9 suppressed the fibril elongation, i.e. modulated the aggregation of 
the preformed nuclei. In turn, as in the case of resveratrol, no arguments were obtained in favor of 
the dye binding to the edge of the ending β-strand, which may inhibit the longitudual fibril growth 
[9,94]. Furthermore, Figure S4 shows that the monomethine compounds, AK7-6 and ThT do not 
compete for the same protein binding sites, making it unlikely that ThT is displaced from the fibril 
side-chain channel, rather its fluorescence intensity is reduced due to the inhibition of insulin 
aggregation. Similarly, the Förster resonance energy transfer between ThT and monomethines is 
hardly possible due to the lack of specific binding of the dyes to amyloid fibrils. 
As seen in Figure 4, the most energetically favorable dye-protein complexes are formed as a result 
of the cyanine binding to different sites of the native insulin: i) AK5-3 and AK7-6 are attached to 
the B-chain α-helix (residues 10–17) and to the B-chain residues 1-4 (β-sheet includes the residues 
B3,B4); ii) AK3-1, AK12-17 and ThT associate with the B-chain residues 17–22 (3-10-helix 
includes the residues B20–B22), as well as to the B-chain residues 1-4 (AK3-1), F1 (ThT), and the 
A-chain α-helix (residues 13–17) (AK12-17); iii) AK3-3 is associated with the B-chain residues 
10–13 and F1. Thus, the typical binding modes for cyanines are (Figure S3): i) the association 
with the B-chain residues 1-4, the B-chain α-helix and/or 3-10-helix, that is preferable for all dyes 
















two partially unfolded insulin monomers [40,95]; ii) the binding between the B-chain C-terminal 
fragment (coil) and the A-chain α-helix (residues 2–8) that is observed for ThT and AK7-6; iii) 
the binding between the B-chain 3-10 helix (residues 20–22) and the A-chain α-helix (residues 
13–17) that is found for AK12-17 and AK3-1; iv) the association with the B-chain C-terminal 
fragment (coil); and v) the association with the A-chain α-helix (residues 2–8) that is revealed for 
AK3-3. On the whole, the cyanines seem to have high affinity for α-, 3-10-helices of the B- chain 
and the A-chain α-helix (residues 13–17), although, e.g., AK12-17 and AK7-6 are characterized 
by multiple binding sites, contrary to the other probes (Figure S3) [95,96]. The latter may reflect 
the low binding affinity of monomethine and heptamethine dyes for the native insulin because of 
the lack of specific binding sites, which also could result in their significantly lower (presumably 
nonspecific) inhibitory effect on the insulin aggregation (Table 1) [79]. The rest of the 
monomethines also lacked the specific binding sites, while the pentamethines were bound to the 
B-chain α- and 3-10 helices, and the trimethines formed stable complexes with both B-chain and 
A-chain helices (data not shown). 
The molecular docking results support the above assumption that the novel dyes are capable 
of stabilizing the native insulin structure by interacting with the B-chain α-helix (comprising the 
residues 11–17 of the amyloid core [40]). Likewise, Congo Red and other organic molecules were 
reported to inhibit the insulin fibrillization [18,97]. In turn, slowing down the insulin 
transformation from α-helical- to β-sheet-rich structure was also induced by 1,2-Bis[4-(3-
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Figure 4.  
Schematic representation of the energetically most favourable dye complexes with fibrillar (A–
E) and native (F–J) insulin, obtained using PatchDock/FireDock servers: AK12-17 (A,G), AK3-
1 (B,H), AK3-3 (C,I), AK5-3 (D,J), AK7-6 (E,K), ThT (F,L). AK7-6 is bound to residues L17 
and Q4, L6 of the first and second protofilaments (B chain) of fibrillar insulin, respectively, 
perpendicular to the main fibril axis, while the other dyes associate with L17 ladder of the B 
chain, located on the dry steric zipper of insulin fibril, parallel to the fibril axis. AK5-3, AK7-6 
are attached to the B-chain α-helix (residues 10–17) and to B-chain residues 1-4 (β-sheet – 
residues B3–B4) of native insulin. AK3-1, AK12-17, ThT – to the B-chain residues 17–22 (3-
10-helix – residues B20–B22), as well as to B-chain residues 1-4 (AK3-1), F1 (ThT), and A-
chain α-helix (residues 13–17) (AK12-17). AK3-3 is associated with the B-chain residues 10–
13 and B-chain residue F1.  
 
unfolded protein conformation compared to the native one [95]. The fact that the hydrophobic 
(e.g., leucine, valine, alanine) and aromatic (e.g., the B-chain F1 and the A-chain Y14) residues, 
constitute the insulin binding site for the cyanine dyes, points to the key role of hydrophobic and 
aromatic intermolecular interactions in the stabilization of the dye-protein complexes. Indeed, 
fibril formation by the human insulin with mutations to more polar residues retarded the amyloid 
nucleation, reflecting the high impact of hydrophobic interactions on the protein aggregation [98]. 
At the same time, the polyphenolic inhibitors (luteolin, transilitin, maritimetin) of Aβ aggregation 
showed the π-π stacking interactions with the peptide [78]. Interestingly, the bovine insulin is 
significantly more prone to fibrillization than the human and porcine insulins due to the A8 residue 
(A-chain) on the protein surface, enhancing the hydrophobic intermolecular interactions [54]. 
From this point of view, the ability of the examined dyes to associate with A8 residue (resulting 
from the fact that these compounds (except monomethines) are characterized by high LogP  
values (Table S1) similar to the cyanine tau aggregation inhibitor compound 11 [35]) could lead 
















of many anti-amyloid therapeutic agents is connected with their tendency to self-associate due to 
strong stacking interactions with aromatic amino acids, the dye ability to prevent insulin from 
aggregation showed inverse correlation with L , suggesting that either the primary inhibition 
mechanism is the stabilization of the α-helical structure (which manifests itself in the retardation 
of the protein nucleation and is supported by the docking studies), or that the dye-protein stacking 
interactions (blocking the lateral extension of β-sheets) are weaker than those within the dye 
assemblies, leading to less pronounced effect on 
maxF  and k  with the increase of L  [99,100]. 
Finally, trimethines occupy both A- and B-chain α-helices, which may be responsible for their ~2–
4 times higher inhibitory potential than that of the pentamethines (Table 1, 
max 0/F F ). Indeed, 
when the B-chain C-terminus was tethered with the A-chain N-terminus, the formation of nontoxic 
amorphous aggregates of the human insulin was observed [101]. It is noteworthy that electrostatic 
interactions can also play essential role in the formation of critical nucleus, as was demonstrated, 
in particular, for the human insulin mutants with altered charge, for which the increase in the lag 
time of amyloid formation was detected [96]. Therefore, the cationic cyanine dyes may inhibit 
insulin nucleation by interaction with negatively charged amino acids, as well. 
Finally, to verify the idea that the inhibitory effect of cyanines on the insulin fibrillization may 
arise from the stabilization of the native protein structure, we performed a series of molecular 
dynamics simulations for the five energetically most stable dye-protein complexes. The backbone 
RMSD and radius of gyration steadily increased as a function of time indicating that the protein 
structure is significantly denatured during about 10 ns (Figures S5–S10,A). The helicity of free 
insulin averaged over all trajectory was ~ 32%. Similarly, three α-helices of the human insulin 
(whose positions are similar to those of bovine insulin) retain about 50% of their structure at 60 
ºC, as revealed by CD measurements [102]. It appeared that the dyes under study are capable of 
stabilizing the insulin native structure (Figure 5A). As illustrated in Figure 5B, the average 
helicity was higher in the presence of cyanines, with the magnitude of this effect increasing in the 
row AK12-17 < AK3-1 < AK7-6 < AK5-3 < AK3-3. In general, this row correlates with the 
inhibition potency of the examined compounds, except AK7-6. The observed stabilization of 
insulin structure under the influence of cyanines may result from their ability to interact with the 
B-chain α-helix as revealed by the molecular docking. Likewise, SASA per residue decreased in 
the B-chain (except AK7-6) and A-chain (except AK12-17) helical regions in the presence of 
cyanines, that is consistent with the involvement of hydrophobic interactions in the formation of 
the dye-protein complex (Figures S5–S10,B) [103]. Similarly, small stress molecules, the 
inhibitors of insulin amyloid formation, improved thermostability of the protein by stabilizing the 
native conformation [97]. Interestingly, AK3-3, possessing the highest inhibition potency, induced 
















S10,C). Thus, the reduced amino acid flexibility supports the suggestion that cyanine compounds 






Figure 5.  
α-helical content of free insulin monomer (InsN) and bound to AK3-3 plotted vs simulation time 
(A). Relative changes in the insulin helicity averaged over MD trajectory (20 ns) in the presence 
of cyanine dyes (B). Schematic illustration of the possible inhibition mechanisms of the insulin 
aggregation by the cyanine dyes (C). Insulin molecules are colored according to the secondary 
structure: helices (magenta and pink), beta-sheet (yellow), turns (cyan) and coil (white).  
 
The decreased backbone RMSD  and radius of gyration (Figures S5–S10,D) provide evidence 
for lower denaturation extent and higher degree of structural compactness of insulin in the presence 
of cyanine dyes. However, the high RMSD  values also suggest that the possibility of the 
stabilization of the partially unfolded insulin conformation by the investigated compounds cannot 
be excluded. The latter can be explained by more favorable binding to the conformations with the 
solvent-exposed hydrophobic residues, as was shown, e.g., for the organic fluorogen BSPOTPE 
















Based on the above results, the possible inhibition mechanisms of the insulin aggregation by 
the cyanine dyes can be outlined as follows (Figure 5C): i) stabilization of the native structure by 
hydrophobic, aromatic and electrostatic interactions, followed by the retardation of the protein 
nucleation (all dyes); ii) blocking the lateral extension of β-sheets via the dye-protein stacking 
interactions (AK3-3, AK3-5, AK5-3, AK5-9). 
 
4. Conclusions 
In conclusion, ThT fluorescence studies revealed that novel cyanine dyes can effectively 
inhibit insulin amyloid fibril formation under physiological conditions in vitro at low dye-protein 
ratio. The compounds possessing the polymethine bridge length of three carbons, long aliphatic 
substituents (especially those containing OH-groups) on the nitrogen atom of benzazole 
chromophore were found to display the highest ability to interfere with the protein aggregation. 
The quantum-chemical calculations, molecular docking and molecular dynamics simulations 
showed that the cyanines suppress the insulin amyloid nucleation presumably by stabilizing the α-
helices of the native state, preventing the toxic oligomers formation, unlike many polyphenols 
(viz., myricetin, baicalein, tannic acid, orcein), which do not interfere with the early nucleation 
events [11,105]. Among the examined dyes, the trimethines AK3-3 and AK3-5 appeared to be the 
most promising compounds for application in pharmacokinetic studies. Specifically, the effect of 
nanomolar concentrations of these dyes on insulin amyloid formation can be measured, as well, to 
enable the design of the anti-amyloid pharmaceutical formulations with the reduced toxicity [33]. 
Furthermore, the above cyanine compounds are expected to easily cross the blood-brain barrier 
due to the high lipophilicity and low molecular weight [33,75,76], to have low cytotoxicity due to 
low affinity for DNA [43], and low ability to exert nonspecific inhibitory effects due to reduced 
degree of self-association.  
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 The studied cyanine dyes possessed high ability to suppress the insulin fibrillization, as 
revealed by ThT fluorescence 
 Quantum-chemical descriptors of trimethines 3-3, 3-5 and pentamethine 5-3 were similar 
to those of known amyloid inhibitors 
 Molecular docking indicated that most of the compounds bound to the helices of the insulin 
monomer 
 The molecular dynamics simulations showed the stabilization of the insulin α-helical 
structure by the cyanines 
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